Article Details
Retrieved on: 2023-11-11 09:08:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was ...
Article found on: www.devdiscourse.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here